A Science and Technology Blog
Information shared by the three stakeholders — NEJM, NIAID and Gilead — on critical issues about whether the drug’s ability to reduce mortality is statistically significant and which category of…
A phase-1 trial using a single dose of a vaccine (Ad5-nCoV) that uses a recombinant adenovirus type-5 vector that carries the genetic material that codes for spike glycoprotein of novel…
Six rhesus macaque monkeys were resistant to reinfection following exposure to novel coronavirus. Compared with nose, the lungs had very less virus when challenged. In another study, the researchers tested…
The Recovery Trial will test five already approved drugs — HIV drug Lopinavir-Ritonavir, anti-inflammatory corticosteroid (dexamethasone), anti-malaria drug hydroxychloroquine and antibiotic azithromycin — on COVID-19 patients. It will also test…
In new guidelines issued on May 6, WHO has backed human challenge studies for COVID-19 vaccines on the ground that it could both accelerate vaccine development and make the final…
Studying adults aged 35 and 41 years who have received BCG vaccine and those who have not received it during childhood, Tel Aviv University researchers found no association between BCG…
Inactivated novel coronavirus vaccine (PiCoVacc) tested on mice, rats and rhesus macaques was found to be safe, and provided partial to complete protection in rhesus macaques depending on the dosage…
A phase-2 trial found that COVID-19 patients with mild to moderate illness had no detectable virus seven days after treatment with a three-drug regimen — oral lopinavir-ritonavir, ribavirin and injectable…
